The "Champagne Cork" procedure for BPH
02 Apr 2024
The Daily Mail's regular "Me and My Operation" feature recently covered the iTIND procedure. This article follow's a patient story with Neil Barber commenting on his role as the surgeon. The iTIND procedure is an addition to the range of minimally invasive procedures for treating BPH - Benign Prostatic Hyperplasia.
Neil Barber and Richard Hindley discuss the iTIND procedure on BBC Radio Surrey
19 Mar 2024
Listen to Neil Barber and Richard Hindley discussing the latest news on treatment options for men with BPH - the iTIND treatment is the latest in minimally invasive options available to patients on the NHS and privately.
Neil Barber chats on Gateway FM on the iTIND procedure for BPH
14 Mar 2024
Spreading the news on iTIND treatment for BPH, Neil Barber chats on Radio Gateway about it's development and the patient's the treatment is suitable for
iTIND - the new prostate treatment changing men's lives - news from BBC South East
19 Mar 2024
Offering our patient's a range of treatment options for their condition and symptoms is key to offering patient choice and there is no "one fits all" solution. The development of iTIND has been led with Neil Barber and both he and Richard Hindley offer this treatment. You can read more from BBC South East here and watch the video too, including a real life patient story.
5 year data for Water Vapour therapy - Richard Hindley discusses on podcast from Boston Scientific
28 Feb 2024
Richard Hindley joined Dr Francesa Cum on a podcast with Boston Scientific to discuss his experience with the Rezum treatment for BPH and the data that the 5 year trials has provided.
'I had enlarged prostate like King Charles and was in excruciating pain but procedure cured me'
19 Jan 2024
As the interest in treatments available for an enlarged prostate continues to rise following the news of King Charles's upcoming treatment, one patient shares his story with the Daily Mirror and the enormous impact finding Neil Barber and choosing Aquablation therapy has had on his life.
Neil Barber completes his 200th Aquablation Procedure at The London Clinic
07 Dec 2023
Whilst Neil Barber has been leading the way introducing Aquablation to the UK through his private practice at The Parkside Suite, Frimley Park Hospital, we are also delighted that The London Clinic also enabled this procedure to be offered to patients in London. Neil recently completed his 200th Aquablation procedure at The London Clinic. In September 2023 NICE guidance confirmed that Aquablation of the prostate should be offered to patients in the NHS as a standard procedure to treat BPH. You can read the full guidance details here.
Keeping your prostate healthy
03 Dec 2023
Neil Barber shares his experience treating men with an enlarged prostate and what you can do to help alleviate and even prevent troublesome symptoms
Reactions to King Charles undergoing surgery for an enlarged prostate
18 Jan 2024
Raising awareness of the impact of an enlarged prostate has received a huge boost with the latest news of King Charles's upcoming surgery for this condition. Richard Hindley spoke to Vanessa Feltz on Talk TV to discuss the symptoms and treatment options that men can choose.
Daily Mail features Aquablation and NICE guidance for standard procedure guidelines on the NHS
04 Nov 2023
Neil Barber and his patient feature in The Daily Mail article on Aquablation therapy for treating Benign Prostatic Hyperplasia.
Men can enjoy life again with a new robotic treatment for BPH
18 Oct 2023
Health Awareness covers the development of Aquablation therapy for BPH featuring comments from Neil Barber and a patient story.
Safety of Aquablation for patients using blood thinnners
10 Oct 2023
Neil Barber is co- author of new publication confirming safety of Aquablation of the prostate in those men who are taking blood thinners - this means that even more men can seek treatment with this image guided, heat free, robotic assisted procedure.
NICE approve Aquablation as a standard procedure across the NHS to treat BPH
14 Sep 2023
We are delighted that NICE has now published it's guidance made on evidence based recommendations that Aquablation should be offered on the NHS as a standard procedure for BPH. The minimally invasive procedure has proven efficacy in the reduction of lower urinary tract symptoms and preservation of sexual function, including ejaculatory function. For many men, this is a key decision maker factor and enables men to make a rapid recovery and return to normal activity.
After some 10 years of involvement in the development of Aquablation of the prostate using the Aquabeam with Procept Biorobotics and 8 years since treating the first patients in the UK and now many hundreds of patients treated, Neil Barber welcomes the news of formal approval for this novel, image guided, heat free surgical treatment for men suffering with prostate related waterworks symptoms
Getting it right first time (GIRFT) and rethinking the treatments for BPH
10 Mar 2023
As the NHS continues to work on "Getting it right first time" (GIRFT), Richard Hindley and his colleagues from the GIRFT academy, share insights onto the pathway for treating men with BPH and the portfolio of minimally invasive options now available
New robot prostate surgery could spell relief for thousands of men
04 Mar 2023
While the European Assoication of Urology (EAU) kicks off it's annual conference in Milan, which features semi live demonstrations of Aquablation, The Daily Express features the procedure and it's impact on NHS backlogs. Neil Barber will be presenting at EAU to share his experience of Aquablation and the trials he is involved in for this exciting new surgery which has results showing excellent efficacy and significantly minimal side affects.
Joining global communities to share Urology expertise
11 Nov 2022
In our latest Blog post, Ahmed Ali and Amr Emara share news on their recent trip to the International Emirates Urological Conference where they shared their experiences on their role in enabling patients to have access to new and innovative treatments for both bladder and prostate conditions. <a title="AA and AE Dubai Conference Update November 2022" href="/storage/repository/cms/files/1/AA%20and%20AE%20Dubai%20Conference%20Update%20November%202022.pdf">Read the full blog post here</a></p>
Why are urinary tract infections more common in women?
27 Oct 2022
In this podcast, Ahmed Ali discusses the causes and symptoms of UTI's and why women suffer more with them.
Studies are showing benefits of bladder preservation based approach
10 Nov 2022
Whilst Urological cancers in both the prostate and kidney are highlighted more in media coverage, bladder cancer continues to require considerable more awarenss campaigns. As calls come for a National Bladder Cancer Audit, <a href="/team.php?team_id=160">Ahmed Ali</a> discusses the bladder preservation techniques he employs when treating patients in thie <a title="AA Mediaplanet Bladder and Bowel November 2022 article only_2" href="/storage/repository/cms/files/1/AA%20Mediaplanet%20Bladder%20and%20Bowel%20November%202022%20article%20only_2.pdf">article</a></p>
5-year data sustain long-term effectiveness of Aquablation vs TURP in BPH
05 Jul 2022
Read the latest study for Aquablation therapy for BPH and it's efficacy compared to the traditional TURP. Neil Barber had a number of patients involved in this trial through Frimley Health Foundation Trust.
Robotic Assisted Surgery for Kidney Cancer - your questions answered
01 Feb 2022
Kidney Cancer UK produced this video to answer all your questions on robotic assisted kidney surgery. With Frimley Health Foundation Trust being a renal cancer centre, Neil Barber works closely with the charity on getting information out to patients on kidney cancer and the continuing research and development for robotic surgery.
SpaceOar treatment for Prostate Cancer patients
10 Dec 2021
Read the latest review of using SpaceOar for patients prior to their prostate cancer treatment. Both Simon Bott and Richard Hindley are able to carry out this procedure for patients before their cancer treatment.
Aquablation extends to Hampshire
05 Jul 2022
Following the successful introduction of Aquablation to Frimley Park Hospital with Neil Barber, Richard Hindley has started trialling the minimally invasive BPH treatment at Hampshire Hospitals. BBC South Today covered the first procedures to discover the impact this could have on burdening NHS waiting lists.
We are delighted to be able to add this procedure to our portfolio of minimally invasive BPH treatments. Neil Barber offers this procedure privately at The London Clinic and Parkside Hospitals. Richard Hindley will be offering this treatment at The Hampshire Clinic - consultations are available with Richard until the procedure can be confirmed here.
ReIMAGINE Prostate Cancer Risk Study
20 Apr 2022
Examining the prostate cancer diagnostic pathway and the risk analysis. As we move to a novel MRI and targeted biopsy approach for diagnostics, this ReIMAGINE study asseses the risks involved in a new diagnostic approach and the need to adjust risk pathways to adapt to these new techniques.
Real world outcomes for Study into Rezum treatment for BPH
12 Apr 2022
The latest study into the efficacy of Rezum treatment has produced real world outcomes with regards to retreatment and significant improvement in symptoms while preserving sexual function. Richard Hindley and Amr Emara worked together on this study alongside additional co-authors.
European School of Urology Webinar
25 Jan 2022
Tonight, Neil Barber is presenting on mininally invaise surgery options for treating male LUTs.
Join tonight and gain CME credits.
Encourage Men to seek help for their Urological problems
30 Nov 2021
This article featured in The Guardian on 30 November 2021. The awareness of prostate cancer is getting better for men, but the majority of prostate issues are NOT cancerous. Benign Prostatic Hyperplasia/Enlargement affects many men over 50 and knowing the symptoms and treatments available can really enable men to get treated and return to their normal lifestyle.
Sky News coverage of robotic kidney surgery
16 Nov 2021
Sky News covered this story on how technology can can ease the burden for the NHS. Muddassar Hussain talks through using robotic kidney suegery to save this patient's kidney using the latest Versius and De Vinci robot at Frimley Health Foundation Trust.
Review of the latest Minimally Invasive Procedures for treating BPH
09 Aug 2021
Over the past 6 years, the treatment options for men suffering with Benign Prostatic Hyperplasia (BPH) has grown with a number of minimally invasive surgical treatment (MISTs) becoming available. Patients can now be offered more than one option, thus allowing lifestyle factors to be included in their decision making alongside their physical symptoms. This article summarises the treatments available, backed up with medical studies results, to show a comparison for patients and medical practitioners. Read the article here <a title="Review of BPH Surgery August 2021_1" href="/storage/repository/cms/files/1/Review%20of%20BPH%20Surgery%20August%202021_1.pdf">Review of BPH Surgery August 2021_1</a></p>
Finding new treatment options for bladder cancer
30 Mar 2021
Having an awareness of symptoms of bladder cancer can make a huge difference to early diagnosis and the type of treatments available to patients. There are other options to consider before going straight to removal of the bladder and these new developments continue to show worthwhile results. Read more from Ahmed Ali in this article featured in The Guardian health supplement.
Focal Therapy Studies prove 8 year efficacy compared to prostatectomy
28 Jan 2021
Richard Hindley and Amr Emara were part of the studies team in this research to look at the longer term efficacy of prostate cancer treatments. Being able to advise our patients on the choices of treatments and how the side affects can vary, allows our patients to make an informed decision in relation to their diagnosis and lifestyle.
Urology Update - LUTS, overactive bladders and bladder cancer
04 Nov 2020
As part of Movember month, Andrew Chetwood, Muddassar Hussain and Ahmed Ali will be speaking at this BMI virtual event to highlight the latest news for Urology and Men's Health. Topics covered include symptoms and treatments for LUTS and BPH, the overactive bladder and bladder cancer.
Treatments for BPH GP Webinar
05 Nov 2020
HCA Princess Grace Hospital are hosting a webinar for GP's where Richard Hindley will be updating you on the latest developments in BPH treatments including Rezum, UroLift and PAE
Fusion guided targeted biopsies proven to be most accurate approach for prostate cancer detection compared to non targeted methods
06 Jul 2020
Neil Barber, Simon Bott and Richard Hindley were all involed in this latest study published in the European Urology Oncology Journal. At Urology Partners, we only use targeted biopsies for diagnosing prostate cancer to get the most accurate diagsnosis for our patients. As well as detecting prostate cancer, the fusion targted approach enables us to differentiate between clinically significant and non significant cancers to enable patients to get the best treatment possible and avoid over diagnosis and unnecessary concern for patients.
NICE publish medical technologies guidance for Rezum
24 Jun 2020
Following further studies for Rezum treatment for BPH with the Rezum II Study, NICE have published the next steps in their medical technologies guidance on the use of Rezum and it's impact on the NHS. Key points from this report highlight the durability and cost benefits associated with Rezum implementation and include:
- Rezum should be used for men with moderate to severe LUTS with an estimated prostate volume of 30 cm3to 80 cm3
- Quality of life is an important outcome when considering patient benefit
- The rate of surgical reintervention is low with Rezum
- Rezum is a day surgery procedure that can be done under local anaesthetic with sedation but it may not be suitable for everyone
- Carrying out Rezum as day surgery is the main driver for cost savings
- Rezum is cost saving when compared to standard treatments such as TURP and HoLEP.
Professor Richard Hindley has been instrumental in the collation of data from his Rezum patients and engaging with NICE as an expert adviser. Having now performed over 600 Rezum cases, we continue to audit our patients and collect data to support the efficacy of this treatment as an option for our patients with BPH.
Patients having Urology procedures during the COVID pandemic remain symptom free
18 May 2020
As our team of Urologists try to balance the COVID pandemic with keeping patients treated and safe, the results from Hampshire Hospitals NHS Foundation Trust provide an insight into what we may be able to achieve whilst complying with all guidelines and processes to keep both patients and medical staff safe.
The results, published in BJU International, indicate that delivering urgent urological surgery during the COVID-19 pandemic appears to be safe with minimal complications post operatively and importantly with no evidence of hospital acquired COVID-19 infections.
Aquablation - 3 year outcomes of WATER trial prove efficacy and durability similar to TURP
26 Feb 2020
Neil Barber has been leading the trials in the UK for Aquablation thereapy for treating BPH. Many patients from the trials came through Frimley Park Hospital with Neil and we are delighted to share the latest results which are proving that this new treatment option is showing results for efficacy and durability similar to TURP - the previous Gold Standard.
BPH - Putting the patient first
20 Feb 2020
As BPH treatments have evolved and now enable patients to make their own choice on the procedure which suits them best, this online conference covers the options available to surgeons and their patients. This includes live surgery and a presentation from Richard Hindley on how new therapies provide different patient benefits.
Genetic test tells patient if prostate cancer is likely to spread
10 Jan 2017
New research has discovered a genetic link to whether localised prostate cancer will advance and spread. If developed, this could allow far more personalised and specific treatment for patients with prostate cancer and knowing how they might respond to treatment.
PROMIS Results Full Report
20 Jan 2017
Read the full report of the PROMIS trials which Richard Hindley.. was part of and bought in 160 patients from Hampshire and Surrey through North Hampshire Hospital</p>
mpMRI for Prostate Cancer diagnosis in Hampshire
15 Feb 2017
Following the news of the PROMIS trials results and the positive data for mpMRI becoming part of the pathway for Prostate Cancer diagnosis, Hampshire Hospitals are able to offer this diagnostic to NHS patients. Richard Hindley was involved in the trial and patients from Hampshire were part of the study. Urology Partners have used mpMRI for diagnosis for a number of years and are delighted to see it move forward under the NHS.
Urolift Benefits for Patients
15 Feb 2017
<iframe src="//www.youtube.com/embed/n-Yi88GwO_w" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p>
How the latest prostate cancer research might affect you
08 Mar 2017
January 2017 saw the results of the PROMIS trial and the evidence confirmed that the use of a Multi Parametric MRI (mpMRI) scan provides a more accurate diagnosis for men before any biopsy has to be considered.<br /><br />This is great news for patients as currently in many hospitals the gold standard is to go straight to Trans Rectal ultrasound guided biopsy (TRUS) which are very hit and miss. As a result, in these hospitals many men without cancer undergo unnecessary biopsies, and some men are over diagnosed with prostate cancer which is actually clinically unimportant. Furthermore the study showed that half of all clinically important cancers (those which need treatment to stop the cancer growing) are missed with the TRUS biopsy method.<br /><br />In addition there are potential side effects, including pain, bleeding and infection.<br /><br />The results of the trial show that one quarter of men may not need to undergo unnecessary prostate biopsy if they undergo an MRI. MRI also detects 93% of important cancers (compared with 48% for TRUS prostate biopsies).<br /><br />It is important for patients to know that with the prostate gland, cancer can be detected but it doesn’t always mean radical treatment is necessary. Clinically insignificant cancer can be present but is unlikely to cause any problems during a man’s lifetime.<br /><br /></p>
Why Urology? Why Spire Clare Park?
15 Mar 2017
<iframe src="//www.youtube.com/embed/NLpeyvksuX0" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p>
Greenlight proves to be cost effective as treatment for BPH
22 Mar 2017
Neil Barber was part of the team behind this study which proves GreenLight XPS provides equivalent clinical outcomes with fewer adverse events and shorter recovery time in a more cost-effective manner compared with TURP as treatment for BPH.
EAU TV 2017
04 Apr 2017
<iframe src="//www.youtube.com/embed/zuPRnG2OM78" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p>
Basingstoke Observer reports on HIFU treatment at NHH
23 May 2017
Recent coverage from the Basingstoke Observer on HIFU treatment available at NHH.
Richard Hindley and the team at North Hampshire Hospital are investing a lot of time and skills into offering the latest treatments in Urology for patients. The results coming in are promising and continue to prove that HIFU is a treatment worth investing in and offers patients further choice on treatment options for prostate cancer.
Urologists in Trials Boost
01 Jun 2017
Coverage in the Basingstoke Gazette of the HIFU trials taking place at North Hampshire hospital led by Richard Hindley. The story also includes comments from a HIFU patient of Richard Hindley and his delight at the procedure outcomes for his prostate cancer
North Hampshire Hospital Pioneers HIFU treatment
27 Jun 2017
Richard Hindley discusses the benefits of HIFU and how North Hampshire Hospital have invested in the technology with the help of the Pelican Cancer Foundation and the North Hants Medical Fund. <br /><br />Being at the forefront of technology and getting involved in the PROMIS trial has allowed Richard Hindley to offer his patients a greater choice of treatment for prostate cancer and the chance to make their own patient choices to suit their lifestyle.</p>Bringing you the latest news in BPH treatments
07 Jun 2017
Urology Partners have always been at the forefront of new and emerging technologies which offer patients minimally invasive treatments to aid symptoms of Benign Prostatic Hyperplasia (BPH).<br /><br />We currently offer <strong><a href="http://www.urologypartners.co.uk/treatments-read-more.asp?ID=12&treatment=Greenlight_Laser_PVP">Greenlight Laser </a></strong>and<strong><a href="http://www.urologypartners.co.uk/treatments-read-more.asp?ID=14&title=Urolift"> Urolift </a></strong>as the latest treatments for BPH. Our consultants have been part of trials for these treatments and have brought a significant number of patients to take part in these trials. Whilst Greenlight is now approved by NICE and Urolift continues in its pathway for NICE approval, the results from the ongoing trials of these treatments are proving successful.</p>
Imaging scientist treated with HIFU using his own technology
27 Jun 2017
HIFU hits the press as the scientist behind medical imaging undergoes treatment for prostate cancer using the very technology he developed.
As part of the PROMIS trial Richard Hindley is quoted in the article discussing the future for prostate cancer diagnosis and treatment benefits from new technology for more precise results.
